Valve membrane adhesion as a cause of Ahmed glaucoma valve failure

Journal of Glaucoma

Volumn 6, Issue 1, 1997, Pages 10-12

  Feldman, Robert M ^a,b   El Harazi, Sherif M ^a   Villanueva, Guillermina ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Hermann Eye Center   (United States)

Author keywords

Ahmed glaucoma valve; Anterior chamber tube shunts; Valve failure

Indexed keywords

FLUORESCEIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; IMPLANT; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; VALVE;

EID: 0031003136     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-199702000-00003     Document Type: Article

References (8)

1. Drake M. Complications of glaucoma filtration surgery. Int Ophthalmol Clin 1992;32:115-30.
2. Melamed S, Cahane M, Gutman I, Blumenthal. Postoperative complications after Malteno implant surgery. Am J Ophthalmol 1991; 11:319-22.
3. Coleman AL, Hill R, Wilson MR, et al. Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol 1995; 120:23-31.
4. Prata JA, Mermoud A, LaBree L, Minckler DS. In vitro and in vivo flow characteristics of glaucoma drainage implants. Ophthalmology 1995;102:894-904.
5. Latina M A. A technique to evaluate fluid flow in glaucoma shunts. Ophthalmic Surg Lasers 1995;26:576-8.
6. Sidoti PA, Morinelli EN, Heuer DK, et al. Tissue plasminogen activator and glaucoma drainage implants. J Glaucoma 1995;4: 258-62.
7. Poster SA, Schumann SP, Staria RJ, Fellman RL. Intracameral tissue plasminogen activator. Management of a fibrin clot occluding a Malteno tube. Ophthalmic Surg 1993;24:853-4.
8. Richards DW. Intracameral tissue plasminogen activator to treat blocked glaucoma implants. Ophthalmic Surg 1993,24:854-5.